APA (7th ed.) Citation

Kreitman, R., Moreau, P., Ravandi, F., Hutchings, M., Gazzah, A., Michallet, A., . . . Subbiah, V. (2023). Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia. Blood, 141(9), . https://doi.org/10.1182/blood.2021013658

Chicago Style (17th ed.) Citation

Kreitman, Robert, et al. "Dabrafenib Plus Trametinib in Patients with Relapsed/refractory BRAF V600E Mutation-positive Hairy Cell Leukemia." Blood 141, no. 9 (2023). https://doi.org/10.1182/blood.2021013658.

MLA (9th ed.) Citation

Kreitman, Robert, et al. "Dabrafenib Plus Trametinib in Patients with Relapsed/refractory BRAF V600E Mutation-positive Hairy Cell Leukemia." Blood, vol. 141, no. 9, 2023, https://doi.org/10.1182/blood.2021013658.